These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16144832)

  • 1. Pias1 interaction and sumoylation of metabotropic glutamate receptor 8.
    Tang Z; El Far O; Betz H; Scheschonka A
    J Biol Chem; 2005 Nov; 280(46):38153-9. PubMed ID: 16144832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
    Dütting E; Schröder-Kress N; Sticht H; Enz R
    Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIAS1-mediated sumoylation of focal adhesion kinase activates its autophosphorylation.
    Kadaré G; Toutant M; Formstecher E; Corvol JC; Carnaud M; Boutterin MC; Girault JA
    J Biol Chem; 2003 Nov; 278(48):47434-40. PubMed ID: 14500712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMOylation attenuates c-Maf-dependent IL-4 expression.
    Lin BS; Tsai PY; Hsieh WY; Tsao HW; Liu MW; Grenningloh R; Wang LF; Ho IC; Miaw SC
    Eur J Immunol; 2010 Apr; 40(4):1174-84. PubMed ID: 20127678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group nucleosomal binding domain 2 (HMGN2) SUMOylation by the SUMO E3 ligase PIAS1 decreases the binding affinity to nucleosome core particles.
    Wu J; Kim S; Kwak MS; Jeong JB; Min HJ; Yoon HG; Ahn JH; Shin JS
    J Biol Chem; 2014 Jul; 289(29):20000-11. PubMed ID: 24872413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast PIAS-type Ull1/Siz1 is composed of SUMO ligase and regulatory domains.
    Takahashi Y; Kikuchi Y
    J Biol Chem; 2005 Oct; 280(43):35822-8. PubMed ID: 16109721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation of GTF2IRD1 regulates protein partner interactions and ubiquitin-mediated degradation.
    Widagdo J; Taylor KM; Gunning PW; Hardeman EC; Palmer SJ
    PLoS One; 2012; 7(11):e49283. PubMed ID: 23145142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CREB SUMOylation by the E3 ligase PIAS1 enhances spatial memory.
    Chen YC; Hsu WL; Ma YL; Tai DJ; Lee EH
    J Neurosci; 2014 Jul; 34(29):9574-89. PubMed ID: 25031400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
    Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
    Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells.
    Wu S; Wright RA; Rockey PK; Burgett SG; Arnold JS; Rosteck PR; Johnson BG; Schoepp DD; Belagaje RM
    Brain Res Mol Brain Res; 1998 Jan; 53(1-2):88-97. PubMed ID: 9473604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes.
    Miyauchi Y; Yogosawa S; Honda R; Nishida T; Yasuda H
    J Biol Chem; 2002 Dec; 277(51):50131-6. PubMed ID: 12393906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates transcriptional repression of E-cadherin.
    Long J; Zuo D; Park M
    J Biol Chem; 2005 Oct; 280(42):35477-89. PubMed ID: 16061479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining calmodulin binding to metabotropic glutamate receptors with distinct protein-interaction methods.
    Lidwell K; Dillon J; Sihota A; O'Connor V; Pilkington B
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):868-70. PubMed ID: 15494036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
    Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
    Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of PIAS1 in the sumoylation of tumor suppressor p53.
    Kahyo T; Nishida T; Yasuda H
    Mol Cell; 2001 Sep; 8(3):713-8. PubMed ID: 11583632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1.
    Chang LK; Lee YH; Cheng TS; Hong YR; Lu PJ; Wang JJ; Wang WH; Kuo CW; Li SS; Liu ST
    J Biol Chem; 2004 Sep; 279(37):38803-12. PubMed ID: 15229220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interaction of AIRE with PIAS1 in transcriptional regulation.
    Ilmarinen T; Kangas H; Kytömaa T; Eskelin P; Saharinen J; Seeler JS; Tanhuanpää K; Chan FY; Slattery RM; Alakurtti K; Palvimo JJ; Ulmanen I
    Mol Immunol; 2008 Apr; 45(7):1847-62. PubMed ID: 18083234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling.
    Rui HL; Fan E; Zhou HM; Xu Z; Zhang Y; Lin SC
    J Biol Chem; 2002 Nov; 277(45):42981-6. PubMed ID: 12223491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
    Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
    PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.